ADVISORY PANEL MAY VOTE ON MONOFOCAL IOL GUIDANCE AS GENERIC PDP PROTOCOL AT OCT. 20 MEETING; DOCUMENT OUTLINES LABELING, CLINICAL TRIAL REQUIREMENTS
This article was originally published in The Gray Sheet
Executive Summary
FDA may ask its Ophthalmic Devices Panel to vote on the adoption of its Sept. 5 draft monofocal intraocular lens guidance as a generic product development protocol at a meeting slated to be held Oct. 20 in Gaithersburg, Maryland.